Literature DB >> 20375862

Ocular toxoplasmosis in the developing world.

J Fernando Arevalo1, Rubens Belfort, Cristina Muccioli, Juan V Espinoza.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20375862     DOI： 10.1097/IIO.0b013e3181d26bf4

Source DB:  PubMed          Journal:  Int Ophthalmol Clin        ISSN： 0020-8167


× No keyword cloud information.
  11 in total

1.  Understanding Toxoplasmosis in the United States Through "Large Data" Analyses.

Authors:  Joseph Lykins; Kanix Wang; Kelsey Wheeler; Fatima Clouser; Ashtyn Dixon; Kamal El Bissati; Ying Zhou; Christopher Lyttle; Andrey Rzhetsky; Rima McLeod
Journal:  Clin Infect Dis       Date:  2016-06-26       Impact factor: 9.079

2.  Clinical manifestation and prognosis of active ocular toxoplasmosis in Iran.

Authors:  Farzan Kianersi; Afsaneh Naderi Beni; Zahra Naderi Beni
Journal:  Int Ophthalmol       Date:  2012-06-26       Impact factor: 2.031

3.  Toxoplasmosis.

Authors:  Sandra K Halonen; Louis M Weiss
Journal:  Handb Clin Neurol       Date:  2013

4.  Ocular toxoplasmosis in Iran: 40 cases analysis.

Authors:  Seidali Tabatabaei; Mohammad Soleimani; Alireza Foroutan; Mehdinili Ahmadabadi; Reza Zarei; Nilofar Piri; Arzhang Gordiz
Journal:  Int J Ophthalmol       Date:  2011-04-18       Impact factor: 1.779

5.  Endochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosis.

Authors:  J Stone Doggett; Aaron Nilsen; Isaac Forquer; Keith W Wegmann; Lorraine Jones-Brando; Robert H Yolken; Claudia Bordón; Susan A Charman; Kasiram Katneni; Tracey Schultz; Jeremy N Burrows; David J Hinrichs; Brigitte Meunier; Vern B Carruthers; Michael K Riscoe
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-10       Impact factor: 11.205

6.  Ciprofloxacin Derivatives Affect Parasite Cell Division and Increase the Survival of Mice Infected with Toxoplasma gondii.

Authors:  Erica S Martins-Duarte; Faustine Dubar; Philippe Lawton; Cristiane França da Silva; Maria de Nazaré C Soeiro; Wanderley de Souza; Christophe Biot; Rossiane C Vommaro
Journal:  PLoS One       Date:  2015-05-07       Impact factor: 3.240

7.  New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infections.

Authors:  Martin McPhillie; Ying Zhou; Kamal El Bissati; Jitender Dubey; Hernan Lorenzi; Michael Capper; Amanda K Lukens; Mark Hickman; Stephen Muench; Shiv Kumar Verma; Christopher R Weber; Kelsey Wheeler; James Gordon; Justin Sanders; Hong Moulton; Kai Wang; Taek-Kyun Kim; Yuqing He; Tatiana Santos; Stuart Woods; Patty Lee; David Donkin; Eric Kim; Laura Fraczek; Joseph Lykins; Farida Esaa; Fatima Alibana-Clouser; Sarah Dovgin; Louis Weiss; Gael Brasseur; Dyann Wirth; Michael Kent; Leroy Hood; Brigitte Meunieur; Craig W Roberts; S Samar Hasnain; Svetlana V Antonyuk; Colin Fishwick; Rima McLeod
Journal:  Sci Rep       Date:  2016-07-14       Impact factor: 4.379

Review 8.  Pathophysiology of ocular toxoplasmosis: Facts and open questions.

Authors:  Valentin Greigert; Faiza Bittich-Fahmi; Alexander W Pfaff
Journal:  PLoS Negl Trop Dis       Date:  2020-12-31

9.  Risk factors for ocular toxoplasmosis in Brazil.

Authors:  A I C Ferreira; C C Brandão De Mattos; F B Frederico; C S Meira; G C Almeida; F Nakashima; C R Bernardo; V L Pereira-Chioccola; L C De Mattos
Journal:  Epidemiol Infect       Date:  2013-03-18       Impact factor: 4.434

10.  Severe South American ocular toxoplasmosis is associated with decreased Ifn-γ/Il-17a and increased Il-6/Il-13 intraocular levels.

Authors:  Alejandra de-la-Torre; Arnaud Sauer; Alexander W Pfaff; Tristan Bourcier; Julie Brunet; Claude Speeg-Schatz; Laurent Ballonzoli; Odile Villard; Daniel Ajzenberg; Natarajan Sundar; Michael E Grigg; Jorge E Gomez-Marin; Ermanno Candolfi
Journal:  PLoS Negl Trop Dis       Date:  2013-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.